Antonio Marchetti

2.8k total citations
39 papers, 1.8k citations indexed

About

Antonio Marchetti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Antonio Marchetti has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Antonio Marchetti's work include Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (9 papers) and Genetic factors in colorectal cancer (6 papers). Antonio Marchetti is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Cancer Genomics and Diagnostics (9 papers) and Genetic factors in colorectal cancer (6 papers). Antonio Marchetti collaborates with scholars based in Italy, United States and Netherlands. Antonio Marchetti's co-authors include Fiamma Buttitta, Lara Felicioni, Maela Del Grammastro, Mattia Barbareschi, Fabio Barassi, Antonio Chella, Sara Malatesta, Andrea Mezzetti, Paolo Palma and Franco Cuccurullo and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Cancer Research.

In The Last Decade

Antonio Marchetti

39 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Marchetti Italy 23 929 878 715 594 177 39 1.8k
Beth Muir United States 11 1.3k 1.4× 970 1.1× 820 1.1× 436 0.7× 156 0.9× 11 2.4k
Yoshio Tomizawa Japan 24 1.1k 1.2× 1.1k 1.2× 991 1.4× 383 0.6× 140 0.8× 72 2.2k
Katherine E. Hutchinson United States 19 972 1.0× 920 1.0× 536 0.7× 595 1.0× 201 1.1× 48 1.8k
Barbara A. Helfrich United States 23 1.7k 1.8× 1.3k 1.4× 959 1.3× 478 0.8× 142 0.8× 35 2.7k
Haruhiro Yukiue Japan 29 839 0.9× 812 0.9× 1.1k 1.5× 352 0.6× 111 0.6× 71 2.0k
Pradip De United States 22 1.0k 1.1× 988 1.1× 438 0.6× 596 1.0× 220 1.2× 36 2.0k
Luigi Formisano Italy 25 1.1k 1.2× 1.1k 1.3× 772 1.1× 494 0.8× 159 0.9× 73 2.2k
Rosa Caputo Italy 20 1.0k 1.1× 1.3k 1.5× 906 1.3× 355 0.6× 163 0.9× 21 2.3k
Karen G. Montgomery Australia 15 1.1k 1.2× 528 0.6× 397 0.6× 362 0.6× 164 0.9× 17 1.6k
Jean‐François Martini United States 18 765 0.8× 1.1k 1.2× 1.2k 1.7× 447 0.8× 155 0.9× 56 2.0k

Countries citing papers authored by Antonio Marchetti

Since Specialization
Citations

This map shows the geographic impact of Antonio Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Marchetti more than expected).

Fields of papers citing papers by Antonio Marchetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Marchetti. The network helps show where Antonio Marchetti may publish in the future.

Co-authorship network of co-authors of Antonio Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Marchetti. A scholar is included among the top collaborators of Antonio Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Marchetti. Antonio Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fassan, Matteo, Valentina Angerilli, Nicola Normanno, et al.. (2024). Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper. Critical Reviews in Oncology/Hematology. 194. 104224–104224. 8 indexed citations
2.
Malapelle, Umberto, Fabio Pagni, Filippo Fraggetta, et al.. (2023). Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group. Critical Reviews in Oncology/Hematology. 193. 104217–104217. 7 indexed citations
3.
Marchetti, Antonio, et al.. (2022). NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies. Pathologica. 114(3). 199–216. 15 indexed citations
4.
Marchetti, Antonio, Mattia Barbareschi, Massimo Barberis, et al.. (2021). Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network. Pathologica. 113(4). 262–271. 12 indexed citations
5.
Cheung, Carol C., Corrado D’Arrigo, Manfred Dietel, et al.. (2016). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 25(4). 227–230. 18 indexed citations
6.
Marchetti, Antonio, Maela Del Grammastro, Lara Felicioni, et al.. (2014). Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment. PLoS ONE. 9(8). e103883–e103883. 121 indexed citations
7.
Vermi, William, Emanuele Giurisato, Silvia Lonardi, et al.. (2013). Ligand-Dependent Activation of EGFR in Follicular Dendritic Cells Sarcoma is Sustained by Local Production of Cognate Ligands. Clinical Cancer Research. 19(18). 5027–5038. 26 indexed citations
8.
Martini, Miriam, Mariangela Russo, Simona Lamba, et al.. (2013). Mixed Lineage Kinase MLK4 Is Activated in Colorectal Cancers Where It Synergistically Cooperates with Activated RAS Signaling in Driving Tumorigenesis. Cancer Research. 73(6). 1912–1921. 16 indexed citations
9.
Stahel, Rolf A., Solange Peters, Paul Baas, et al.. (2013). Strategies for improving outcomes in NSCLC: A look to the future. Lung Cancer. 82(3). 375–382. 29 indexed citations
10.
Buttitta, Fiamma, Lara Felicioni, Maela Del Grammastro, et al.. (2012). Effective Assessment of egfr Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing. Clinical Cancer Research. 19(3). 691–698. 88 indexed citations
11.
Romagnoli, Solange, Ester Fasoli, Valentina Vaira, et al.. (2009). Identification of Potential Therapeutic Targets in Malignant Mesothelioma Using Cell-Cycle Gene Expression Analysis. American Journal Of Pathology. 174(3). 762–770. 40 indexed citations
12.
Mancini, Francesca, Giusy Di Conza, Marsha Pellegrino, et al.. (2009). MDM4 (MDMX) localizes at the mitochondria and facilitates the p53‐mediated intrinsic‐apoptotic pathway. The EMBO Journal. 28(13). 1926–1939. 67 indexed citations
13.
Buttitta, Fiamma, Simona Lamba, Luca Cardone, et al.. (2008). AKT1E17K in human solid tumours. Oncogene. 27(42). 5648–5650. 175 indexed citations
14.
Giglio, Simona, Francesca Mancini, Lara Felicioni, et al.. (2005). Identification of an Aberrantly Spliced Form of HDMX in Human Tumors: A New Mechanism for HDM2 Stabilization. Cancer Research. 65(21). 9687–9694. 47 indexed citations
15.
Marchetti, Antonio, Caterina Pellegrini, Fiamma Buttitta, et al.. (2002). Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation. Laboratory Investigation. 82(6). 729–736. 41 indexed citations
16.
Marchetti, Antonio, Silvia Pellegrini, Gloria Bertacca, et al.. (1998). FHIT andp53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. The Journal of Pathology. 184(3). 240–246. 41 indexed citations
17.
Barbareschi, Mattia, Orazio Caffo, Fiamma Buttitta, et al.. (1997). Cyclin-d1-gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochemical expression. International Journal of Cancer. 74(2). 171–174. 62 indexed citations
18.
Barbareschi, Mattia, Emanuela Bonoldi, Antonio Marchetti, et al.. (1996). Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Annals of Oncology. 7(7). 695–703. 49 indexed citations
19.
Marchetti, Antonio, et al.. (1990). Cardiac toxicity and antitumor activity of 4′-deoxy-4′-iodo-doxorubicinol. Cancer Chemotherapy and Pharmacology. 26(6). 403–408. 7 indexed citations
20.
Bernardini, Nunzia, et al.. (1990). Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats. Cancer Chemotherapy and Pharmacology. 25(5). 326–332. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026